FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890854321> ?p ?o ?g. }

• W2890854321 abstract "Background A post-hoc analysis of the PARADIGM-HF clinical trial demonstrated treatment with sacubitril/valsartan resulted in a significant reduction in patients with worsening NYHA functional class, as compared to enalapril. Additional post-hoc analyses have revealed a reduction in intensification in outpatient diuretics, as well as a reduction in overall daily diuretic requirements, for patients treated with sacubitril/valsartan verses enalapril. Real world evidence is limited in analyzing patient experiences surrounding improvement in HF symptoms and diuretic usage. Methods This analysis was a retrospective chart review of patients consecutively prescribed sacubitril/valsartan at the Jefferson Heart Institute from January 1, 2016 until January 31, 2017. Patient clinical outcomes and diuretic requirements were analyzed for 3 months following maintenance on any dose of sacubitril/valsartan for four weeks. Chart examinations reviewed documentation for improvements in heart failure (HF) symptoms, NYHA functional class, and LVEF, as well as changes in concomitant HF medications. Safety endpoints included symptomatic hypotension and an elevation in serum creatinine and/or potassium. Results A total of 42 patients were included in the analysis. Thirty-six patients (85.7%) were titrated from their initial starting dose, although only 28 patients (66.7%) reached the targeted dose of 97/103mg twice daily. Fifty-seven percent of the patients (24/42) reported improvements in their HF-related symptoms, while 38.1% (16/42) of the patients demonstrated improvement NYHA functional classification. Thirty-six patients were concomitantly receiving loop diuretics during the initiation of sacubitril/valsartan, of whom 6 (16.7%) and 14 patients (38.9%) required discontinuation and dose reductions of loop diuretics, respectively. Twenty-two patients had a repeat ECHO after sacubitril/valsartan was initiated, fourteen of whom (63.6%) showed improvements in their LVEF. Two patients required discontinuation of therapy due to an adverse reaction; however, no other discontinuations were required from symptomatic hypotension, hyperkalemia or renal impairment. Sixteen patients (38%) experienced symptomatic hypotension, and 50% of those patients were not titrated to the target dose. Conclusion Treatment with sacubitril/valsartan resulted in an improvement in patient-reported HF symptoms, NYHA functional class and LVEF. Although the majority of patients were maintained on diuretics post initiation of sacubitril/valsartan, daily dose reductions were observed. Patients did not require discontinuation of therapy as a result of symptomatic hypotension, hyperkalemia and/or renal impairment. Despite a small sample size, this retrospective analysis serves as an example of real world experience with initiating sacubitril/valsartan in patients with chronic HFrEF." @default.
• W2890854321 created "2018-09-27" @default.
• W2890854321 creator A5005773437 @default.
• W2890854321 creator A5044768601 @default.
• W2890854321 creator A5051113171 @default.
• W2890854321 date "2018-08-01" @default.
• W2890854321 modified "2023-09-24" @default.
• W2890854321 title "An Analysis on Clinical Outcomes and Diuretic Requirements Following Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure with Reduced Ejection Fraction" @default.
• W2890854321 doi "https://doi.org/10.1016/j.cardfail.2018.07.090" @default.
• W2890854321 hasPublicationYear "2018" @default.
• W2890854321 type Work @default.
• W2890854321 sameAs 2890854321 @default.
• W2890854321 citedByCount "0" @default.
• W2890854321 crossrefType "journal-article" @default.
• W2890854321 hasAuthorship W2890854321A5005773437 @default.
• W2890854321 hasAuthorship W2890854321A5044768601 @default.
• W2890854321 hasAuthorship W2890854321A5051113171 @default.
• W2890854321 hasConcept C126322002 @default.
• W2890854321 hasConcept C164705383 @default.
• W2890854321 hasConcept C27016395 @default.
• W2890854321 hasConcept C2775940317 @default.
• W2890854321 hasConcept C2775999527 @default.
• W2890854321 hasConcept C2776754050 @default.
• W2890854321 hasConcept C2777387769 @default.
• W2890854321 hasConcept C2778198053 @default.
• W2890854321 hasConcept C2779918671 @default.
• W2890854321 hasConcept C2781117629 @default.
• W2890854321 hasConcept C71924100 @default.
• W2890854321 hasConcept C78085059 @default.
• W2890854321 hasConcept C84393581 @default.
• W2890854321 hasConceptScore W2890854321C126322002 @default.
• W2890854321 hasConceptScore W2890854321C164705383 @default.
• W2890854321 hasConceptScore W2890854321C27016395 @default.
• W2890854321 hasConceptScore W2890854321C2775940317 @default.
• W2890854321 hasConceptScore W2890854321C2775999527 @default.
• W2890854321 hasConceptScore W2890854321C2776754050 @default.
• W2890854321 hasConceptScore W2890854321C2777387769 @default.
• W2890854321 hasConceptScore W2890854321C2778198053 @default.
• W2890854321 hasConceptScore W2890854321C2779918671 @default.
• W2890854321 hasConceptScore W2890854321C2781117629 @default.
• W2890854321 hasConceptScore W2890854321C71924100 @default.
• W2890854321 hasConceptScore W2890854321C78085059 @default.
• W2890854321 hasConceptScore W2890854321C84393581 @default.
• W2890854321 hasLocation W28908543211 @default.
• W2890854321 hasOpenAccess W2890854321 @default.
• W2890854321 hasPrimaryLocation W28908543211 @default.
• W2890854321 hasRelatedWork W2786919783 @default.
• W2890854321 hasRelatedWork W2808475246 @default.
• W2890854321 hasRelatedWork W2890854321 @default.
• W2890854321 hasRelatedWork W2923219557 @default.
• W2890854321 hasRelatedWork W2924108789 @default.
• W2890854321 hasRelatedWork W3029174432 @default.
• W2890854321 hasRelatedWork W3089594192 @default.
• W2890854321 hasRelatedWork W4200158067 @default.
• W2890854321 hasRelatedWork W4206115596 @default.
• W2890854321 hasRelatedWork W4213070686 @default.
• W2890854321 isParatext "false" @default.
• W2890854321 isRetracted "false" @default.
• W2890854321 magId "2890854321" @default.
• W2890854321 workType "article" @default.